§ 13F · FUND PROFILE
TCG Crossover Management, LLC.
AUM · $4.2B (13F)Positions · 54Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$426M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | 6.01M | $801M | 19.2% | −7% |
| 2 | TNGX | TANGO THERAPEUTICS INC | 9.08M | $284M | 6.8% | −14% |
| 3 | CGON | CG ONCOLOGY INC | 3.67M | $261M | 6.3% | ±0% |
| 4 | COGT | COGENT BIOSCIENCES INC | 4.85M | $188M | 4.5% | −2% |
| 5 | IMVT | IMMUNOVANT INC | 4.46M | $172M | 4.1% | ±0% |
| 6 | SYRE | SPYRE THERAPEUTICS INC | 1.90M | $169M | 4.1% | ±0% |
| 7 | DNTH | DIANTHUS THERAPEUTICS INC | 1.68M | $163M | 3.9% | ±0% |
| 8 | MIRM | MIRUM PHARMACEUTICALS INC | 1.06M | $124M | 3.0% | ±0% |
| 9 | ZLAB | ZAI LAB LTD-ADR | 6.14M | $117M | 2.8% | NEW |
| 10 | AMLX | AMYLYX PHARMACEUTICALS INC | 6.24M | $112M | 2.7% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE TCG SIGNAL
AC read
TCG Crossover Management, LLC is a Other fund managing $4.2 billion in assets. The fund runs a portfolio of 54 positions.
Read the full dossier →